ScreenerHero

EVFM Evofem Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · evofem.com
0.0074USD0.00%Mkt Cap: 980722 $P/E: —

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a ho…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap980.72K USD
Enterprise Value60.19M USD
Revenue (TTM)18.05M USD
Gross Profit15.57M USD
Net Income (TTM)391.00K USD
Revenue/Share0.14 USD
Last Price0.0074 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30048L2034
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-13.62
EV/Revenue3.34
P/S0.05
P/B-0.01
EPS (TTM)-0.11
EPS (Forward)-0.55
52W Range
0.001034% of range0.0200
52W High0.0200 USD
52W Low0.0010 USD
Profitability
Gross Margin77.12%
Oper. Margin-94.53%
EBITDA Margin-24.49%
Profit Margin1.94%
ROE-0.53%
ROA1.93%
Growth
Revenue Growth-45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.99M USD
CapEx (TTM)5.00K USD
FCF Margin35.52%
FCF Yield653.47%
Net Debt54.18M USD
Net Debt/EBITDA-12.26
Balance Sheet
Debt/Equity-0.73
Current Ratio0.07
Quick Ratio0.03
Book Value/Sh-0.66 USD
Cash/Share0.0010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2018
Splits
Last Split1:125
Split DateMay 18, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.53M
Float132.53M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float11.01%
Short % Out.10.98%
Shares Short69.46K
Short (prev mo.)142.57K
Technical
SMA 500.0077 (-4.1%)
SMA 2000.0083 (-11.2%)
Beta-1.36
S&P 52W Chg16.45%
Avg Vol (30d)111.60K
Avg Vol (10d)66.23K
Technical Indicators
RSI (14)48.2
MACD-0.0001
MACD Signal-0.0001
MACD Hist.-0.0000
BB Upper0.0082 USD
BB Middle0.0076 USD
BB Lower0.0069 USD
BB Width17.82%
ATR (14)0.0005 USD
Vol Ratio (20d)0.00x